Takao HANAOKA
Takao HANAOKA publishes mostly in Surgery, Pulmonary and Respiratory Medicine and Epidemiology, on topics such as Metastasis and carcinoma case studies, Gastrointestinal Tumor Research and Treatment and Cholangiocarcinoma and Gallbladder Cancer Studies.
- World rank
- #6,164,708 of 7,710,434 ranked researchers
- Rank in Japan
- #235,180 of 383,136
- Works
- 31
- Citations
- 107
- Citations per work
- 3.5
What does Takao HANAOKA research?
Takao HANAOKA's work is mostly in Medicine (58%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1858.1%
- Medicine1858.1%
- Everything else1238.4%
- Life Sciences13.5%
- 1Surgery22% of their works
- 2Pulmonary and Respiratory Medicine19% of their works
- 3Epidemiology6% of their works
- 4Oncology6% of their works
- 5Gastroenterology6% of their works
- 6Immunology4% of their works
Research topics
- Metastasis and carcinoma case studies
- Gastrointestinal Tumor Research and Treatment
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Gastric Cancer Management and Outcomes
- Renal Transplantation Outcomes and Treatments
- Multiple and Secondary Primary Cancers
- Hepatocellular Carcinoma Treatment and Prognosis
- Lung Cancer Diagnosis and Treatment
Which keywords describe Takao HANAOKA's research?
The keywords of their largest research topics: Prognostic Factors, Surgical Management, Adjuvant Therapy, Chemotherapy, Lung Tumors, Metastatic Carcinomas, Biliary Tract Cancer and Cholangiocarcinoma.
- Second Primary Neoplasms
- Lung Cancer
- Hepatocellular Carcinoma
- Renal Allograft
- Gastric Cancer
- Sunitinib
- Cholangiocarcinoma
- Metastatic Carcinomas
- Chemotherapy
- Surgical Management
- Prognostic Factors
- Adjuvant Therapy
- Lung Tumors
- Biliary Tract Cancer
- Imatinib Mesylate
- Endoscopic Resection
- Kidney Transplantation
- CT Screening
- Liver Cancer
- Multiple Primary Cancers
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Prognostic Factors82 topics
- Surgical Management82 topics
- Adjuvant Therapy52 topics
- Chemotherapy52 topics
- Lung Tumors51 topic
- Metastatic Carcinomas51 topic
- Biliary Tract Cancer41 topic
- Cholangiocarcinoma41 topic
- Imatinib Mesylate41 topic
- Sunitinib41 topic
- Endoscopic Resection31 topic
- Gastric Cancer31 topic
- Kidney Transplantation31 topic
- Renal Allograft31 topic
- CT Screening21 topic
- Hepatocellular Carcinoma21 topic
- Liver Cancer21 topic
- Lung Cancer21 topic
- Multiple Primary Cancers21 topic
- Second Primary Neoplasms21 topic
Where does Takao HANAOKA work?
Takao HANAOKA's main affiliation in the publication record is Nakadōri General Hospital, Japan.
How many publications and citations does Takao HANAOKA have?
OpenAlex counts 31 works and 107 citations for Takao HANAOKA, an h-index of 6, ranking #6,164,708 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Takao HANAOKA. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.